Melanopsin retinal ganglion cell loss in Alzheimer disease

Chiara La Morgia1,2, Fred N Ross-Cisneros3, Yosef Koronyo4

  • 1IRCCS Institute of Neurological Sciences of Bologna, Bellaria Hospital, Bologna, Italy.

Annals of Neurology
|October 28, 2015
PubMed
Abstract

Insights

Alzheimer disease (AD) patients show reduced retinal nerve fiber layer thickness and significant loss of melanopsin retinal ganglion cells (mRGCs). This mRGC degeneration, linked to amyloid-beta deposition, contributes to circadian rhythm dysfunction in AD.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Chronobiology

Background:

  • Melanopsin retinal ganglion cells (mRGCs) are crucial for circadian photoentrainment.
  • Circadian dysfunction is a hallmark of Alzheimer disease (AD).

Purpose of the Study:

  • To investigate the role of mRGCs in the circadian dysfunction observed in Alzheimer disease.
  • To hypothesize that mRGCs contribute to circadian dysfunction in AD.

Main Methods:

  • Assessed retinal nerve fiber layer (RNFL) thickness using optical coherence tomography (OCT) in AD patients.
  • Evaluated rest-activity circadian rhythm via actigraphy.
  • Studied postmortem mRGCs and optic nerve axons using immunohistochemistry.
  • Coimmunostained for amyloid-beta (Aβ) deposition and melanopsin.

Main Results:

  • Demonstrated age-related optic neuropathy in AD with reduced RNFL thickness and axonal loss.
  • Observed significant loss of mRGCs and abnormal mRGC morphology in postmortem AD retinas.
  • Found Aβ accumulation within and around mRGCs in AD retinas.
  • Noted reduced sleep efficiency in AD patients, indicating circadian dysfunction.

Conclusions:

  • Showed variable rest-activity circadian dysfunction in AD patients.
  • Demonstrated age-related optic nerve axon loss and specific mRGC pathology in AD.
  • Concluded that mRGC degeneration, associated with Aβ deposition, contributes to circadian rhythm dysfunction in Alzheimer disease.